Lemon balm (Melissa officinalis L.): An evidence-based systematic review by the natural standard research collaboration

Journal of Herbal Pharmacotherapy

Volumn 5, Issue 4, 2006, Pages 71-114

  Brendler, Thomas ^a   Gruenwald, Joerg ^b   Kligler, Benjamin ^a   Keifer, David ^c   Abrams, Tracee Rae ^d   Woods, Jen ^e   Boon, Heather ^f   DeFranco Kirkwood, Catherine ^g   Basch, Ethan ^h   Lafferty, Hope J ^h   Ulbricht, Catherine ^a   Hackman, Dana A ^e  

^a Natural Standard Research Collaboration   (Germany)

^b PhytoPharm Consulting   (Germany)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF RHODE ISLAND   (United States)

^e NORTHEASTERN UNIVERSITY   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g Natural Standard   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANGELICA ARCHANGELICA EXTRACT; ANTIGLAUCOMA AGENT; BARBITURIC ACID DERIVATIVE; CARUM CARVI EXTRACT; CHAMOMILE; CHELIDONIUM EXTRACT; CINNAMON EXTRACT; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; ESSENTIAL OIL; GLYCYRRHIZA GLABRA EXTRACT; HERBACEOUS AGENT; HERPILYN; HUMULUS LUPULUS EXTRACT; HYPERICUM PERFORATUM EXTRACT; KAVA EXTRACT; KLOSTERFRAU MELISSENGEIST; LOMAHERPAN; MATRICATA RECUTITA EXTRACT; MELISSA OFFICINALIS EXTRACT; NICOTINE; NUTMEG OIL; ORANGE EXTRACT; PEPPERMINT; PLANT EXTRACT; SCOPOLAMINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SILYBUM MARIANUM EXTRACT; SONGHA NIGHT; THYROID HORMONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALERIAN;

AGITATION; ANXIETY DISORDER; BURNING SENSATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; COLITIS; CONTACT DERMATITIS; DEMENTIA; DIARRHEA; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DYSPEPSIA; EEG ABNORMALITY; ENDOCRINE DISEASE; ERYTHEMA; EVIDENCE BASED MEDICINE; EYE DISEASE; FATIGUE; GASTROINTESTINAL DISEASE; HEADACHE; HEART PALPITATION; HERPES SIMPLEX; HISTORY OF MEDICINE; HUMAN; HYPERSENSITIVITY REACTION; IBERIS AMARA; INTRAOCULAR HYPERTENSION; LACTATION; MATRICATA RECUTITA; MEDICAL EXPERT; MEDICINAL PLANT; MELISSA OFFICINALIS; NAUSEA; NEUROLOGIC DISEASE; PARESTHESIA; PHARMACODYNAMICS; PIGMENT DISORDER; POSTMARKETING SURVEILLANCE; PREGNANCY; PRIORITY JOURNAL; SCIENTIFIC LITERATURE; SHORT SURVEY; SKIN DISEASE; SKIN IRRITATION; SLEEP DISORDER; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TRADITIONAL MEDICINE;

EVIDENCE-BASED MEDICINE; HUMANS; MELISSA; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 33746511987     PISSN: 15228940     EISSN: 15229106     Source Type: Journal    
DOI: 10.1300/J157v05n04_08     Document Type: Short Survey

References (112)

1. Coleta, M., Campos, M. G., Cotrim, M. D., and Proenca, da Cunha. Comparative. evaluation of Melissa officinalis L., Tilia europaea L., Passiflora edulis Sims.and Hypericum perforation L. in the elevated plus maze anxiety test. Pharmacopsychiatry 2001;34 Suppl 1:S20-S21.
2. Kennedy, D. O., Wake, G., Savelev, S., Tildesley, N. T., Perry, E. K., Wesnes, K. A.,and Scholey, A. B. Modulation of mood and cognitive performance following acute administration of single doses of Melissa officinalis (Lemon balm) with human CNS nicotinic and muscarinic receptor-binding properties. Neuropsychopharmacology 2003;28(10):1871-188 1.
3. Kennedy, D. O., Little, W., and Scholey, A. B. Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosom.Med. 2004;66(4):607-613.
4. Perry, E. K., Pickering, A. T., Wang, W. W., Houghton, P., and Perry, N. S. Medicinal plants and Alzheimer's disease: Integrating ethnobotanical and contemporary scientific evidence. J. Altern. Complement Med. 1998;4(4):419-428.
5. Perry, E. K., Pickering, A. T., Wang, W. W., Houghton, P. J., and Perry, N. S. Medicinal plants and Alzheimer's disease: From ethnobotany to phytotherapy. J. Pharm. Pharmacol. 1999;51(5):527-534.
6. Ramos, Ruiz A., De la Torre, R. A., Alonso, N., Villaescusa, A., Betancourt, J., and Vizoso, A. Screening of medicinal plants for induction of somatic segregation activity in Aspergillus nidulans. J. Ethnopharmacol. 7-5-1996;52(3):123-127.
7. Herrmann, E. C., Jr. and Kucera, L. S. Antiviral substances in plants of the mint family (Labiatae). II. Nontannin polyphenol of Melissa officinalis. Proc. Soc. Exp. Biol. Med. 1967;124(3):869-874.
8. Hohmann, J., Zupko, I., Redei, D., Csanyi, M., Falkay, G., Mathe, I., and Janicsak, G.Protective effects of the aerial parts of Salvia officinalis, Melissa officinalis and Lavandula angustifolia and their constituents against enzyme-dependent and enzyme-independent lipid peroxidation. Planta. Med. 1999;65(6):576-578.
9. Kucera, L. S. and Herrmann, E. C., Jr. Antiviral substances in plants of the mint family (Labiatae). I. Tannin of Melissa officinalis. Proc. Soc. Exp. Biol. Med. 1967; 124(3): 865-869.
10. Lamaison, J. L., Petitjean-Freytet, C., and Carnat, A. [Medicinal Lamiaceae with antioxidant properties, a potential source of rosmarinic acid]. Pharm. Acta Helv. 1991;66(7):185-188.
11. Triantaphyllou, K., Blekas, G., and Boskou, D. Antioxidative properties of water extracts obtained from herbs of the species Lamiaceae. Int. J. Food Sci. Nutr. 2001; 52(4):313-317.
12. Dragland, S., Senoo, H., Wake, K., Holte, K., and Blomhoff, R. Several culinary and medicinal herbs are important sources of dietary antioxidants. J. Nutr. 2003; 133(5):1286-1290.
13. Soulimani, R., Fleurentin, J., Mortier, F., Misslin, R., Derrieu, G., and Pelt, J.M. Neurotropic action of the hydroalcoholic extract of Melissa officinalis in the mouse. Planta. Med. 1991;57(2):105-109.
14. Wake, G., Court, J., Pickering, A., Lewis, R., Wilkins, R., and Perry, E. CNS acetylcholine receptor activity in European medicinal plants traditionally used to improve failing memory. J. Ethnopharmacol. 2000;69(2):105-114.
15. Sadraei, H., Ghannadi, A., and Malekshahi, K. Relaxant effect of essential oil of Melissa officinalis and citral on rat ileum contractions. Fitoterapia 2003;74(5):445-452.
16. Farnsworth, N. R., Bingel, A. S., Cordell, G. A., Crane, F. A., and Fong, H. H. Potential value of plants as sources of new antifertility agents I. J. Pharm. Sci. 1975; 64(4):535-598.
17. Khayyal, M. T., el Ghazaly, M. A., Kenawy, S. A., Seif-el-Nasr, M., Mahran, L. G., Kafafl, Y. A., and Okpanyi, S. N. Antiulcerogenic effect of some gastrointestinally acting plant extracts and their combination. Arzneimittelforschung 2001;51(7):545-553.
18. Forster, H. B., Niklas, H., and Lutz, S. Antispasmodic effects of some medicinal plants. Planta. Med. 1980;40(4):309-319.
19. Israel, D. and Youngkin, E. Q. Herbal therapies for perimenopausal and menopausal complaints. Pharmacotherapy 1997; 17(5):970-984.
20. Kennedy, D. O., Scholey, A. B., Tildesley, N. T., Perry, E. K., and Wesnes, K. A. Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacol. Biochem. Behav. 2002;72(4):953-964.
21. Kucera, L. S., Cohen, R. A., and Herrmann, E. C., Jr. Antiviral activities of extracts of the lemon balm plant. Ann N.Y. Acad. Sci. 7-30-1965; 130(1):474-482.
22. Koytchev, R., Alken, R. G., and Dundarov, S. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine 1999;6(4):225-230.
23. Wolbling, R. H. and Milbradt, R. [Clinical manifestations and treatment of Herpes simplex infections]. Therapiewoche 1984;34:1193-1200.
24. Wolbling, R. H. and Leonhardt, K. Local therapy of herpes simplex with dried extract from Melissa officinalis. Phytomedicine 1994;1:25-31.
25. May, G. and Willuhn,G. [Antiviral effect of aqueous plant extracts in tissue culture]. Arzneimittelforschung 1978;28(1):1-7.
26. Yamasaki, K., Nakano, M., Kawahata, T., Mori, H., Otake, T., Ueba, N., Oishi, I., Inami, R., Yamane, M., Nakamura, M., Murata, H., and Nakanishi, T. Anti-HIV-1 activity of herbs in Labiatae. Biol. Pharm. Bull. 1998;21(8):829-833.
27. Wong, A. H., Smith, M., and Boon, H. S. Herbal remedies in psychiatric practice. Arch. Gen. Psychiatry 1998;55(11):1033-1044.
28. Berdonces, J. L. [Attention deficit and infantile hyperactivity]. Rev. Enferin. 2001;24(1):11-14.
29. Galasinski, W., Chlabicz, J., Paszkiewicz-Gadek, A., Marcinkiewicz, C., and Gindzienski, A. The substances of plant origin that inhibit protein biosynthesis. Acta Pol.Pharm. 1996;53(5):311-318.
30. Chlabicz, J. and Galasinski, W. The components of Melissa officinalis L. that influence protein biosynthesis in-vitro. J. Pharm. Pharmacol. 1986;38(11):791-794.
31. Auf'mkolk, M., Ingbar, J. C., Kubota, K., Amir, S. M., and Ingbar, S. H. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins. Endocrinology 1985;116(5): 1687-1693.
32. Auf'mkolk, M., Ingbar, J. C., Amir, S. M., Winterhoff, H., Sourgens, H., Hesch, R. D.and Ingbar, S. H. Inhibition by certain plant extracts of the binding and adenylate cyclase stimulatory effect of bovine thyrotropin in human thyroid membranes. Endocrinology 1984;115(2):527-534.
33. Sourgens, H., Winterhoff, H., Gumbinger, H. G., and Kemper, F. H. Antihormonal effects of plant extracts. TSH- and prolactin-suppressing properties of Lithospermum officinale and other plants. Planta Med. 1982;45(2):78-86.
34. Cerny, A. S. and Schmid, K. Tolerability and efficacy of valerian/lemon balm in healthy volunteers; a double-blind placebo-controlled, multicentre study. Fitoterapia 1999;70(3):221-228.
35. Kennedy, D., Scholey, A., Tildesley, N., and Wesnes, K. Dose-dependent changes in mood and cognitive performance following single doses of Melissa officinalis (Lemon Balm) to healthy young adults. Proceedings of the British Psychological Society 2001;9(2):209.
36. Dressing, H. Valerian combination therapy vs. benzodiazepine: Same efficacy in the treatment of sleeping disorders? Therapiewoche 1992;42(12):726-736.
37. Buchner, K.H., Hellings, H., Huber, M., Peukert, E., Spath, L., and Deininger, R. [Double blind study as evidence of the therapeutic effect of Melissengeist on psycho-vegetative syndromes]. Medizinische Klinik 1974;69(23):1032-1036.
38. Auf'mkolk, M., Kohrle, J., Gumbinger, H., Winterhoff, H., and Hesch, R. D. Antihormonal effects of plant extracts: Iodothyronine deiodinase of rat liver is inhibited by extracts and secondary metabolites of plants. Horm. Metab. Res. 1984;16(4): 188-192.
39. Ballard, C. G., O'Brien, J. T., Reichelt, K., and Perry, E. K. Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: The results of a double-blind, placebo-controlled trial with Melissa. J. Clin. Psychiatry 2002;63(7):553-558.
40. Patora, J., Majda, T., Gora, J., and Klimek, B. Variability in the content and composition of essential oil from lemon balm (Melissa officinalis L.) cultivated in Poland. Acta Pol. Pharm. 2003;60(5):395-400.
41. Adzet, T., Ponz, R., and Schulte E. Genetic variability of the essential oil content of Melissa officinalis. 1992;58:558-561.
42. Adzet, T., Ponz, R., Wolf, E., and Schulte, E. Content and composition of M. officinalis oil in relation to leaf position and harvest time. 1992;58:562-564.
43. Baerheim-Svendsen, A. and Merkx, IJ. A simple method for screening of fresh plant material for glycosidic bound volatile compounds. 1989;55:38-40.
44. Hose, S., Zänglein, A., Berg, T. van den, Schultze, W., Kubeczka, K. H., and Czygan, F. C. Die Pharmazie. Im. Druck. Ontogenetic variation of the essential leaf oil of Melissa officinalis L. 1997; 52(3):247-253.
45. Mrlianova, M., Tekel'ova, D., Felklova, M., Reinohl, V., and Toth, J. The influence ofthe harvest cut height on the quality of the herbal drugs Melissae folium and Melissae herba. Planta Med. 2002;68(2):178-180.
46. Mrlianova, M., Tekel'ova, D., Felklova, M., Toth, J., Musil, P., and Grancai, D. [Comparison of the quality of Melissa officinalis L. cultivar Citra with Mellissas of European origin]. Ceska. Slov. Farm. 2001;50(6):299-302.
47. Vaverkova, S., Holla, M., and Takel, J. [The content and quality of Melissa officinalis essential oil after application of Rastim 30 DKV]. Ceska. Slov. Farm. 2001;50(1):46-50.
48. Patora, J. and Klimek, B. Flavonoids from lemon balm (Melissa officinalis L., Lamiaceae). Acta Pol. Pharm. 2002;59(2):139-143.
49. Ziakova, A., Brandsteterova, E., and Blahova, E. Matrix solid-phase dispersion for the liquid chromatographic determination of phenolic acids in Melissa officinalis. J Chromatogr. A 1-3-2003;983(1-2):271-275.
50. Araujo, C., Sousa, M. J., Ferreira, M. F., and Leao, C. Activity of essential oils from Mediterranean Lamiaceae species against food spoilage yeasts. J. Food Prot. 2003;66(4):625-632.
51. Dimitrova, Z., Dimov, B., Manolova, N., Pancheva, S., Ilieva, D., and Shishkov, S. Antiherpes effect of Melissa officinalis L. extracts. Acta Microbiol Bulg. 1993; 29:65-72.
52. Heitz, A., Carnat, A., Fraisse, D., Carnat, A. P., and Lamaison, J. L. Luteolin 3′-glucuronide, the major flavonoid from Melissa officinalis subsp. officinalis. Fitoterapia 2000;71(2):201-202.
53. Palma, S. D., Manzo, R. H., and Allemandi, D. A. Dry plant extracts loaded on fumed silica for direct compression: Preparation and preformulation. Pharm. Dev. Technol. 1999;4(4):523-530.
54. Hener, U., Faulhaber, S., Kreis, P., and Mosandl, A. On the authenticity evaluation of balm oil (Melissa officinalis L.). 1995;50:60-62.
55. Schultze, W., König, W.A., Hilkert, A., and Richter, R. Melissenöle/Untersuchungen zur Echtheit mittels enantioselektiver Gaschromatographie und Isotopenverhältnis- Massenspektrometric. 1995;135:557, 563 567, 571, 577-557, 564, 568, 574, 577.
56. Schultze, W., Zänglein, A., Klose, R., and Kubeczka, K. H. Die Melisse/Dünnschichtchromatographische Untersuchung des ätherischen Öles. 1989; 129: 155-163.
57. Tabatabai, A. S., Buchbauer, G., Jirovetz, L., and Nikiforov, A. Vergleichende Untersuchungen verschiedener Proben von Melissen-und Citronell-äOlen mittels GC-FID und GC-FTIR-MS sowie Multivar Datenanalayse. 1995;63(4):352.
58. Wolf, J. Melissenblatter/Mikro-Dunnschichtchromatographie. 1996;141(25): 2316.
59. Tekel, J., Vaverkova, S., Kovacicova, J., Hola, M., and Havranek, E. A screening method for the determination of the residues of uracil herbicides in Melissa officinalis L. 1994;49(899):901.
60. Berg, T. van den, Freundl, E., and Czygan, F. C. Melissa officinalis ssp. altissima: Characteristics of a possible adulteration of lemon balm. 1997;52(10): 802-808.
61. Nakashima, M. J. and Glaze, L. E. Extraction of light filth from whole leaves of alfalfa, lemon balm, papaya, and spearmint: Collaborative study. J. Assoc. Off. Anal. Chem. 1987;70(6):997-999.
62. Akhondzadeh, S., Noroozian, M., Mohammadi, M., Ohadinia, S., Jamshidi, A. H., and Khani, M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomised, placebo controlled trial. J. Neurol. Neurosurg. Psychiatry 2003;74(7):863-866.
63. Madisch, A., Melderis, H., Mayr, G., Sassin, I., and Hotz, J. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study]. Z Gastroenterol. 2001;39(7):511-517.
64. Ward, N. I. and Savage, J. M. Metal dispersion and transportational activities using food crops as biomonitors. Sci. Total Environ. 5-23-1994;146-147:309-319.
65. West, I. and Maibach, H. I. Contact urticaria syndrome from multiple cosmetic components. Contact Dermatitis 1995;32(2):121.
66. Hausen, B. M. and Schulze, R. [Comparative studies of the sensitizing capacity of drug used in herpes simplex]. Derm Beruf. Umwelt. 1986;34(6):163-170.
67. Schulz, H., Jobert, M., and Hubner, W. D. The quantitative EEG as a screening instrument to identify sedative effects of single doses of plant extracts in comparison with diazepam. Phytomedicine 1998;5:449-458.
68. Herberg, K. W. Nebenwirkungen pflanzlicher Beruhigungsmittel/Leistung und Befinde nach Einnahme einer Baldrian-Hopfen-Kombination. Z. Allg. Med. 1996; 72:234-240.
69. Santini, F., Vitti, P., Ceccarini, G., Mammoli, C., Rosellini, V., Pelosini, C., Marsili, A., Tonacchera, M., Agretti, P., Santoni, T., Chiovato, L., and Pinchera, A. In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity. J. Endocrinol. Invest. 2003;26(10):950-955.
70. Gyllenhaal, C., Merritt, S. L., Peterson, S. D., Block, K. I., and Gochenour, T. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med. Rev. 2000;4(3):229-251.
71. Agata, I., Kusakabe, H., Hatano, T., Nishibe, S., and Okuda, T. Melitric acids A and B, new trimeric caffeic acid derivatives from Melissa officinalis. Chem. Pharm. Bull. 1993;41(9):1608-1611.
72. Tagashira, M. and Ohtake, Y. New antioxidative 1,3-benzodioxole from Melissa officinalis. Planta. Med. 1988;64(6):555-558.
73. Englberger, W., Hadding, U., Etschenberg, E., Graf, E., Leyck, S., Winkelmann, J., and Parnham, M. J. Rosmarinic acid: A new inhibitor of complement C3- convertase with anti-inflammatory activity. Int. J. Immunopharmacol. 1988;10(6):729-737.
74. Cohen, R. A., Kucera, L.S., and Herrmann, E. C. Antiviral activity of Melissa officinalis (lemon balm) extract (29600). Proceedings of the Society for Experimental Biology and Medicine 1964;117:431-434.
75. Felklova, M., Natherova, L., and Duskova, K. [Tannin compounds in leaves of Melissa officinalis L., invaded by Septoria melissae Desm]. Cesk. Farm. 1969;18(9): 457-460.
76. Mulkens, A. and Kapetanidis, I. [Flavonoids of the leaves of Melissa officinalis L. (Lamiaceae)]. Pharm.Acta Helv. 1987;62(1):19-22.
77. Thieme, H. and Kitze, C. [Occurrence of flavonoids in Melissa officinalis L]. Pharmazie 1973;28(1):69-70.
78. Mikus, J., Harkenthal, M., Steverding, D., and Reichling, J. In vitro effect of essential oils and isolated mono- and sesquiterpenes on Leishmania major and Trypanosoma brucei. Planta Med 2000;66(4):366-368.
79. Brieskorn, C. H. and Krause, W. [Further triterpenes from Melissa officinalis L. (author's transl)]. Arch Pharm.(Weinheim) 1974;307(8):603-612.
80. Tittel, G., Wagner, H., and Bos, R. [Chemical composition of the essential oil from Melissa]. Planta Medica 1982;46:91-98.
81. Hefendehl, F. W. [Composition of etheric oil of Melissa officinalis L. and secondary changes of oil composition]. Arch Pharm. Ber. Dtsch. Pharm. Ges. 1970;303(4): 345-357.
82. Mulkens, A. and Kapetanidis, I. Eugenylglucoside, a new natural Phenylpropanoid Heteroside from Melissa officinalis. J. Nat. Prod. 1988;51:496-498.
83. Mulkens, A., Stephanou, E., and Kapetanidis, I. Heterosides a genines volatiles dans les feuilles de Melissa officinalis L. (Lamiaceae). Pharma Acta Helv 1985;60: 276-278.
84. Sarer, E. and Kökdil, G. Constituents of the essential oil from Melissa officinalis. Planta Med 1991;57:89-90.
85. Mulkens, A. and Kapetanidis, I. Etude de l'huile essentielle de Melissa officinalis L. (Laminaceae). Pharm Acta Helv. 1988;63:266-270.
86. Carnat, A. P., Carnat, A., Fraisse, D., and Lamaison, J. L. The aromatic and polyphenolic: Composition of lemon balm (Melissa officinalis L., subsp officinalis) tea. 1998;72:301-305.
87. Koch-Heitzmann, I. and Czygan, F. C. Über wasserdampfflüchtige Diterpenkohlenwasserstoffe in nicht differenzierten Oberflachenkulturen Untersuchungen an Kalluskulturen von Melissa officinalis L. 1985;II(40c):13-20.
88. Allahverdiyev, A., Duran, N., Ozguven, M., and Koltas, S. Antiviral activity of the volatile oils of Melissa officinalis L. against Herpes simplex virus type-2. Phytomedicine. 2004;11(7-8):657-661.
89. Larrondo, J. V., Agut, M., and Calvo-Torras, M. A. Antimicrobial activity of essences from labiates. Microbios 1995;82(332):171-172.
90. Iauk, L., Lo Bue, A. M., Milazzo, I., Rapisarda, A., and Blandino, G. Antibacterial activity of medicinal plant extracts against periodontopathic bacteria. Phytother. Res. 2003;17(6):599-604.
91. Friedman, M., Henika, P. R., Levin, C. E., and Mandrell, R. E. Antibacterial activities of plant essential oils and their components against Escherichia coli O157:H7 and Salmonella enterica in apple juice. J. Agric. Food Chem. 9-22-2004;52(19): 6042-6048.
92. Mimica-Dukic, N., Bozin, B., Sokovic, M., and Simin, N. Antimicrobial and antioxidant activities of Melissa officinalis L. (Lamiaceae) essential oil. J. Agric. Food Chem. 5-5-2004;52(9):2485-2489.
93. Peake, P. W., Pussell, B. A., Martyn, P., Timmermans, V., and Charlesworth, J. A. The inhibitory effect of rosmarinic acid on complement involves the C5 convertase. Int. J. Immunopharmacol. 1991;13(7):853-857.
94. Dimpfel, W., Pischel, I., and Lehnfeld, R. Effects of lozenge containing lavender oil, extracts from hops, lemon balm and oat on electrical brain activity of volunteers. Eur. J. Med. Res. 9-29-2004;9(9):423-431.
95. Ivanova, D., Gerova, D., Chervenkov, T., and Yankova, T. Polyphenols and antioxidant capacity of Bulgarian medicinal plants. J. Ethnopharmacol. 1-4-2005;96(1-2): 145-150.
96. Marongiu, B., Porcedda, S., Piras, A., Rosa, A., Deiana, M., and Dessi, M. A. Antioxidant activity of supercritical extract of Melissa officinalis subsp. officinalis and Melissa officinalis subsp. inodora. Phytother. Res. 2004;18(10):789-792.
97. de Sousa, A. C., Alviano, D. S., Blank, A. F., Alves, P. B., Alviano, C. S., and Gattass,C. R. Melissa officinalis L. essential oil: Antitumoral and antioxidant activities. J. Pharm. Pharmacol. 2004;56(5):677-681.
98. Drozd, J. and Anuszewska, E. The effect of the Melissa officinalis extract on immune response in mice. Acta Pol. Pharm. 2003;60(6):467-470.
99. McCue, P. P. and Shetty, K. Inhibitory effects of rosmarinic acid extracts on porcine pancreatic amylase in vitro. Asia Pac. J. Clin. Nutr. 2004;13(1):101-106.
100. Soulimani, R., Younos, C., Fleurentin, J., Mortiert, F., Misslin, R., and Derrieux, G.Recherche de l'Activit, biologique de Melissa officinalis L. sur le Systéme nerveux central de la souris in vivo et le Doudenum de Rat in vitro. Plant Med Phytother 1993;26:77-85.
101. Salah, S. M. and Jager, A. K. Screening of traditionally used Lebanese herbs for neurological activities. J. Ethnopharmacol. 2-10-2005;97(1):145-149.
102. Gazola, R., Machado, D., Ruggiero, C., Singi, G., and Macedo, Alexandre M. Lippia alba, Melissa officinalis and Cymbopogon citratus: Effects of the aqueous extracts on the isolated hearts of rats. Pharmacol. Res. 2004;50(5):477-480.
103. Vogt, M., Tausch, I., Wölbling, R. H., and Kaiser P. M. [Melissa extract in herpes simplex: A double-blind placebo-controlled study]. Der Allgemeinarzt 1991; 13:832-841.
104. Lagoni, N. Wirksamkeitsprüfung eines pflanzlichen Tagessedativums in einer multizentrischen Studie. 1998;39(3):166-169.
105. Schmidt, U., Krieger, W., Frerick, H., and Schenk, N. Psychosomatische und psychische Störungen/Baldrian und Melisse statt synthetischer Psychopharmaka. 1992; 14:15-19.
106. Chakurski, L, Matev, M., Koichev, A., Angelova, I., and Stefanov, G. [Treatment of chronic colitis with an herbal combination of Taraxacum officinale, Hipericum perforatum, Melissa officinalis, Calendula officinalis and Foeniculum vulgarel. Vutr.Boles. 1981;20(6):51-54.
107. Madisch, A., Holtmann, G., Mayr, G., Vinson, B., and Hotz, J. Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial. Digestion 2004;69(1):45-52.
108. Borho, B. Biologische Therapie von funktionellen Magenerkrankungen. 1991;6: 501-509.
109. Dressing, H., Kohler, S., and Muller, W. E. Improvement in sleep quality with a high dose valerian-melissa preparation. Psychopharmakotherapie 1996;3:123-130.
110. Lindahl, O. and Lindwall, L. Double blind study of a valerian preparation. Pharmacol. Biochem. Behav. 1989;32(4):1065-1066.
111. Widy-Tyszkiewicz, E., and Schminda, R. A randomized double blind study of sedative effects of phytotherapeutic containing valerian, hops, balm and motherwort versus placebo. Herb Polon. 1997;2:154-159.
112. Orth-Wagner, S., Ressin, W. J., and Friedrich, I. Phytosedativum gegen Schlafstörungen/Klinische Wirksamkeit und Verträglichkeit eines Phytosedativums mit Auszügen aus Baldrianwurzel, Hopfenzapfen und Melissenblättern. 1995; 16(147): 156.